X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (94) 94
Patent (31) 31
Publication (8) 8
Book Review (3) 3
Conference Proceeding (2) 2
Book Chapter (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (35) 35
biochemistry (34) 34
microbiology (33) 33
beer (31) 31
enzymology (31) 31
metallurgy (31) 31
mutation or genetic engineering (31) 31
spirits (31) 31
vinegar (31) 31
wine (31) 31
humans (26) 26
animals (24) 24
compositions thereof (24) 24
culture media (24) 24
index medicus (24) 24
microorganisms or enzymes (24) 24
propagating, preserving or maintaining microorganisms (24) 24
cancer (21) 21
human necessities (21) 21
hygiene (21) 21
medical or veterinary science (21) 21
preparations for medical, dental, or toilet purposes (21) 21
compositions or test papers therefor (14) 14
condition-responsive control in microbiological orenzymological processes (14) 14
ligands (14) 14
measuring or testing processes involving enzymes, nucleicacids or microorganisms (14) 14
processes of preparing such compositions (14) 14
biochemistry & molecular biology (13) 13
cell line, tumor (13) 13
oncology (12) 12
aptamer (11) 11
aptamers, nucleotide - therapeutic use (10) 10
mice (10) 10
proteins (10) 10
rats (10) 10
cell biology (9) 9
general tagging of cross-sectional technologies spanning over several sections of the ipc (9) 9
general tagging of new technological developments (9) 9
kinases (9) 9
selex (9) 9
technical subjects covered by former us classification (9) 9
technical subjects covered by former uspc (9) 9
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (9) 9
nucleic acids (8) 8
selex aptamer technique (8) 8
apoptosis (7) 7
aptamers (7) 7
biotechnology & applied microbiology (7) 7
growth (7) 7
medicine, research & experimental (7) 7
patz1 (7) 7
review (7) 7
aptamers, nucleotide - pharmacology (6) 6
enzymes (6) 6
glial cell line-derived neurotrophic factor (6) 6
identification (6) 6
in-vitro selection (6) 6
molecular biology (6) 6
pc12 cells (6) 6
protein folding (6) 6
proto-oncogene proteins c-ret (6) 6
proto-oncogene proteins c-ret - metabolism (6) 6
research article (6) 6
signal transduction (6) 6
systematic evolution (6) 6
tyrosine (6) 6
aptamers, nucleotide - genetics (5) 5
aptamers, nucleotide - metabolism (5) 5
archaea (5) 5
article (5) 5
biology (5) 5
biotechnology (5) 5
breast cancer (5) 5
derivatives thereof (5) 5
differentiation (5) 5
endocrine system diseases (5) 5
epidermal growth factor (5) 5
expression (5) 5
glioma (5) 5
medicine (5) 5
molecular sequence data (5) 5
multidisciplinary sciences (5) 5
nucleosides (5) 5
nucleotides (5) 5
oncogene (5) 5
organic chemistry (5) 5
phosphorylation (5) 5
receptor protein-tyrosine kinases - antagonists & inhibitors (5) 5
receptor protein-tyrosine kinases - metabolism (5) 5
research paper (5) 5
rodents (5) 5
stem cells (5) 5
sugars (5) 5
tumors (5) 5
activation (4) 4
aptamers, nucleotide - chemistry (4) 4
archaeal proteins - chemistry (4) 4
blood-brain barrier (4) 4
brain cancer (4) 4
cell movement (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancers, ISSN 2072-6694, 05/2018, Volume 10, Issue 5, p. 132
The most common approaches to cancer treatment have been, for decades, based on surgical excision, radio- and/or chemotherapy, which, in spite of their modest... 
ONCOLOGY | Aptamers | Cancer | n/a
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 12/2017, Volume 18, Issue 12, p. 2524
Journal Article
Cancers, ISSN 2072-6694, 10/2017, Volume 9, Issue 10, p. 134
Journal Article
Pharmaceuticals, ISSN 1424-8247, 11/2018, Volume 11, Issue 4, p. 123
Compared to other breast cancers, triple-negative breast cancer (TNBC) usually affects younger patients, is larger in size, of higher grade and is biologically... 
Tumor microenvironment | Targeted therapy | Chemoresistance | Aptamer | Targeted imaging | TNBC | SELEX | targeted therapy | chemoresistance | aptamer | targeted imaging | tumor microenvironment
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 9, p. e24071
Nucleic acid aptamers have been developed as high-affinity ligands that may act as antagonists of disease-associated proteins. Aptamers are non immunogenic and... 
LUNG-CANCER | INDUCED ACTIVATION | CETUXIMAB | TARGETED THERAPIES | EPIDERMAL-GROWTH-FACTOR | BIOLOGY | RESISTANCE | ERBB SIGNALING NETWORK | TYROSINE KINASES | TUMOR-CELLS | FACTOR RECEPTOR | Aptamers, Nucleotide - pharmacology | Cell Survival - drug effects | Lung Neoplasms - drug therapy | Caspase 9 - metabolism | Apoptosis - drug effects | Humans | Lung Neoplasms - metabolism | Caspase 3 - metabolism | Caspase 8 - metabolism | Antibodies, Monoclonal - therapeutic use | Aptamers, Nucleotide - therapeutic use | Drug Resistance, Neoplasm | Immunoblotting | Antineoplastic Agents - therapeutic use | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Animals | Flow Cytometry | Mice, Nude | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Cetuximab | Tyrosine | Biological products | Epidermal growth factor | RNA | Gliomas | Monoclonal antibodies | Biochemistry | Lung cancer, Non-small cell | Apoptosis | Drugs | Toxicity | Biological evolution | Brain tumors | Lung cancer | Antagonists | Drug delivery | Neuroblastoma | Drug development | Kinases | Cancer therapies | Cell surface | Proteins | Xenografts | Biocompatibility | Nuclease | Gefitinib | Protein-tyrosine kinase | Decoys | Epidermal growth factor receptors | Non-small cell lung carcinoma | Breast cancer | FDA approval | Ribonucleic acid--RNA | Inhibitors | Glioma | Immunogenicity | Cell death | Medical prognosis | Neutralizing | Aptamers | Ligands | Combined treatment | Mutation | Gene therapy | Tumors | Cancer | Ribonucleic acid
Journal Article
Cancer Letters, ISSN 0304-3835, 2015, Volume 370, Issue 1, pp. 100 - 107
Journal Article
Journal Article
Central Nervous System Agents in Medicinal Chemistry, ISSN 1871-5249, 06/2015, Volume 15, Issue 2, pp. 126 - 137
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 35, pp. 59282 - 59300
Glioblastoma (GBM), the most malignant of the brain tumors, has been classified on the basis of molecular signature into four subtypes: classical, mesenchymal,... 
Tumor heterogeneity | Glioma stem cells | Biomarker | Glioma | PATZ1 | CANCER-CELL PLASTICITY | CLASSIFICATION | biomarker | PREDICT PROGNOSIS | IDENTIFICATION | glioma stem cells | TUMORS | CELL BIOLOGY | HETEROGENEITY | ONCOGENE | GENE | GROWTH | glioma | CENTRAL-NERVOUS-SYSTEM | tumor heterogeneity
Journal Article
BBA - Reviews on Cancer, ISSN 0304-419X, 04/2018, Volume 1869, Issue 2, pp. 263 - 277
Journal Article